Vinorelbine, Pertuzumab, and Trastuzumab for Breast Cancer Vinorelbine, Pertuzumab, and Trastuzumab for Breast Cancer

Is the combination of vinorelbine with dual HER2-targeted therapy a good first-line option for patients needing an alternative to docetaxel?Breast Cancer Research

Source: Medscape Today Headlines - April 27, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news